Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-025791
Filing Date
2019-04-24
Accepted
2019-04-24 18:07:46
Documents
2
Period of Report
2019-04-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 15120
2 POA DOCUMENT poa.txt EX-24.4_848886 3039
  Complete submission text file 0001209191-19-025791.txt   19724
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address
GORDON CARL L (Reporting) CIK: 0001282930 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38871 | Film No.: 19764848

Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 225 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Issuer) CIK: 0001595893 (see all company filings)

EIN.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations